BRAFMutation Status in Gastrointestinal Stromal Tumors

MicroRNA-206 expression is down-regulated in estrogen receptor a-positive human breast cancer.

(2010) N Kondo et al.   CANCER RESEARCH

Gastrointestinal stromal tumors: report of an audit and review of the literature

(2009) Guido Biasco et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Gene Expression Profiling of Papillary Thyroid Carcinoma Identifies Transcripts Correlated with BRAF Mutational Status and Lymph Node Metastasis

(2008) G. Oler et al.   CLINICAL CANCER RESEARCH

Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors

(2008) Narasimhan P. Agaram et al.   GENES CHROMOSOMES & CANCER

BRAFV600EMutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study

(2008) Rossella Elisei et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Phospho-ERK Staining Is a Poor Indicator of the Mutational Status of BRAF and NRAS in Human Melanoma

(2008) Roland Houben et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

In melanocytic lesions the fraction of BRAFV600E alleles is associated with sun exposure but unrelated to ERK phosphorylation

(2008) Tiziana Venesio et al.   MODERN PATHOLOGY

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

(2008) J. Tsai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA